المؤلفون: Beyaert SP; Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Loriot AE; Group of Computational Biology and Bioinformatics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Huyghe ND; Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Goebbels RM; Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Mendola A; Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium., Govaerts AS; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Fortpied C; European Organization of Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Baldin P; Department of Pathology, Cliniques Universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium., Licitra LF; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; University of Milan, Milan, Italy., Lalami Y; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Machiels JH; Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium.; Department of Medical Oncology, Institut Roi Albert II & Cliniques Universitaires Saint-Luc, Brussels, Belgium., Schmitz S; Institut de Recherche Expérimentale et Clinique (IREC), pôle MIRO, Université catholique de Louvain (UCLouvain), Brussels, Belgium.; Department of Head & Neck Surgery, Institut Roi Albert II & Cliniques Universitaires Saint-Luc, Brussels, Belgium.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 13; Vol. 29 (20), pp. 4076-4087.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

المؤلفون: Harrington KJ; The Institute of Cancer Research/The Royal Marsden National Institute for Health Research Biomedical Research Centre, London, UK., Soulières D; Hôpital Notre-Dame, Montreal, QC, Canada., Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, Paris and Saint-Cloud, France.; INSERM U900 Research Unit, Saint-Cloud, France.; Paris-Saclay University, Paris, France., Dinis J; Instituto Português Oncologia, Porto, Portugal., Licitra LF; Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy., Ahn MJ; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Soria A; Hospital Universitario Ramón y Cajal, Madrid, Spain., Machiels JH; Cliniques Universitaires Saint-Luc, Brussels, Belgium., Mach N; HUG - Hôpitaux Universitaires de Genève, Geneva, Switzerland., Mehra R; Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA., Burtness B; Yale University School of Medicine, New Haven, CT, USA., Ellison MC; Merck & Co, Inc, Kenilworth, NJ, USA., Cheng JD; Merck & Co, Inc, Kenilworth, NJ, USA., Chirovsky DR; Merck & Co, Inc, Kenilworth, NJ, USA., Swaby RF; Merck & Co, Inc, Kenilworth, NJ, USA., Cohen EEW; Moores Cancer Center at UC San Diego Health, University of California San Diego, La Jolla, CA, USA.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Feb 01; Vol. 113 (2), pp. 171-181.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Neoplasm Recurrence, Local/*drug therapy , Squamous Cell Carcinoma of Head and Neck/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cetuximab/administration & dosage ; Cetuximab/adverse effects ; Disease-Free Survival ; Docetaxel/administration & dosage ; Docetaxel/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/pathology ; Patient Reported Outcome Measures ; Quality of Life ; Squamous Cell Carcinoma of Head and Neck/pathology

المؤلفون: de Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori, Medical Oncology Department, University of Milan, via G. Venezian, 1, 20133 Milan, Italy., Machiels JH; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Avenue Hippocrate 10, 200 Woluwe-Saint-Lambert, 1200 Brussels, Belgium., Boggiani D; Medical Oncology Unit, University Hospital of Parma, Via Antonio Gramsci 14, 43126 Parma, Italy., Rottey SWH; Drug Research Unit Ghent, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium., Duca M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian, 1, 20133 Milan, Italy., Laruelle M; Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université catholique de Louvain, Avenue Hippocrate 10, 200 Woluwe-Saint-Lambert, 1200 Brussels, Belgium., Salvagni S; Policlinico S. Orsola Malphigi, via Giuseppe Massarenti, 13, 40138 Bologna, Italy., Damian S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian, 1, 20133 Milan, Italy., Lapeire LDF; Drug Research Unit Ghent, Ghent University Hospital, Corneel Heymanslaan 10, 9000 Ghent, Belgium., Tiseo M; Medical Oncology Unit, University Hospital of Parma, Via Antonio Gramsci 14, 43126 Parma, Italy., Dermine A; Institut Roi Albert II, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université catholique de Louvain, Avenue Hippocrate 10, 200 Woluwe-Saint-Lambert, 1200 Brussels, Belgium., Ould-Kaci M; Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Rd, Ridgefield, CT 06877, USA., Braunger J; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach an der Riß, Germany., Rascher J; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach an der Riß, Germany., Fischer D; Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397 Biberach an der Riß, Germany., Hoefler J; Staburo GmbH, Aschauer Str. 26b, 81549 Munich, Germany, on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Mariani GL; Boehringer Ingelheim, via Giovanni Lorenzini, 8, 20139 Milan, Italy., Cresta S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, via G. Venezian, 1, 20133 Milan, Italy.

المصدر: Cancers [Cancers (Basel)] 2020 May 31; Vol. 12 (6). Date of Electronic Publication: 2020 May 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

المؤلفون: Galot R; Department of Medical Oncology, Institut Roi Albert II - Cliniques universitaires Saint-Luc, Brussels, Belgium; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium., van Marcke C; Department of Medical Oncology, Institut Roi Albert II - Cliniques universitaires Saint-Luc, Brussels, Belgium; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium; Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Helaers R; Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Mendola A; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium., Goebbels RM; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium., Caignet X; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium., Ambroise J; Institute for Clinical and Experimental Research (CTMA), Université catholique de Louvain, Brussels, Belgium., Wittouck K; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium., Vikkula M; Laboratory of Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Limaye N; Genetics of Autoimmune Diseases and Cancer, de Duve Institute, Université catholique de Louvain, Brussels, Belgium., Machiels JH; Department of Medical Oncology, Institut Roi Albert II - Cliniques universitaires Saint-Luc, Brussels, Belgium; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium. Electronic address: jean-pascal.machiels@uclouvain.be.

المصدر: Oral oncology [Oral Oncol] 2020 May; Vol. 104, pp. 104631. Date of Electronic Publication: 2020 Mar 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE

مواضيع طبية MeSH: High-Throughput Nucleotide Sequencing/*methods , Liquid Biopsy/*methods , Squamous Cell Carcinoma of Head and Neck/*surgery, Female ; Humans ; Male ; Neoplasm Metastasis ; Neoplasm Recurrence, Local

المؤلفون: Galot R; Department of Medical Oncology, Institut Roi Albert II - Cliniques universitaires Saint-Luc, Brussels, Belgium; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium., Machiels JH; Department of Medical Oncology, Institut Roi Albert II - Cliniques universitaires Saint-Luc, Brussels, Belgium; Institute for Clinical and Experimental Research (MIRO), Université catholique de Louvain, Brussels, Belgium. Electronic address: jean-pascal.machiels@uclouvain.be.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2020 Apr; Vol. 85, pp. 101992. Date of Electronic Publication: 2020 Feb 14.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*genetics , Circulating Tumor DNA/*blood , Head and Neck Neoplasms/*genetics , Head and Neck Neoplasms/*pathology , Squamous Cell Carcinoma of Head and Neck/*genetics , Squamous Cell Carcinoma of Head and Neck/*pathology, Biopsy, Needle ; Female ; Humans ; Immunohistochemistry ; Male ; Monitoring, Physiologic/methods ; Neoplasm Invasiveness/pathology ; Neoplasm Staging ; Prognosis ; Sensitivity and Specificity

المؤلفون: Springuel L; Celyad SA, Mont-Saint-Guibert, Belgium., Lonez C; Celyad SA, Mont-Saint-Guibert, Belgium., Alexandre B; Celyad SA, Mont-Saint-Guibert, Belgium., Van Cutsem E; University Hospitals Leuven and KU Leuven, Leuven, Belgium., Machiels JH; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Van Den Eynde M; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Prenen H; University Hospital Antwerp (UZ Antwerp), Antwerp, Belgium., Hendlisz A; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Shaza L; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Carrasco J; Grand Hôpital de Charleroi (GHdC), Charleroi, Belgium., Canon JL; Grand Hôpital de Charleroi (GHdC), Charleroi, Belgium., Opyrchal M; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Odunsi K; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Rottey S; Ghent University Hospital, Ghent, Belgium., Gilham DE; Celyad SA, Mont-Saint-Guibert, Belgium., Flament A; Celyad SA, Mont-Saint-Guibert, Belgium., Lehmann FF; Celyad SA, Mont-Saint-Guibert, Belgium. flehmann@celyad.com.

المصدر: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2019 Oct; Vol. 33 (5), pp. 515-537.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE

مواضيع طبية MeSH: Cell- and Tissue-Based Therapy/*methods , Neoplasms/*therapy , Receptors, Chimeric Antigen/*therapeutic use , Tumor Microenvironment/*immunology, Animals ; Cell- and Tissue-Based Therapy/adverse effects ; Clinical Trials as Topic ; Humans ; Neoplasms/immunology ; T-Lymphocytes/immunology ; T-Lymphocytes/transplantation

المؤلفون: Lonez C; Celyad, Mont-Saint-Guibert, Belgium., Hendlisz A; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Shaza L; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Aftimos P; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Vouche M; Department of Radiology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Donckier V; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Machiels JH; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Belgium., Van Den Eynde M; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Belgium., Canon JL; Service d'Oncologie-Hématologie, Site Notre-Dame, Grand Hôpital de Charleroi (GHdC), Belgium., Carrasco J; Service d'Oncologie-Hématologie, Site Notre-Dame, Grand Hôpital de Charleroi (GHdC), Belgium., Odunsi K; Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States., Sahebjam S; H Lee Moffitt Cancer Center and Research Inst, Tampa, FL, United States., Rottey S; Ghent University Hospital, Ghent, Belgium., Braun N; Celyad, Mont-Saint-Guibert, Belgium., Verma B; Celyad, New York, NY, United States., Gilham DE; Celyad, Mont-Saint-Guibert, Belgium., Lehmann FF; Celyad, Mont-Saint-Guibert, Belgium. Electronic address: flehmann@celyad.com.

المصدر: Current research in translational medicine [Curr Res Transl Med] 2018 May; Vol. 66 (2), pp. 53-56. Date of Electronic Publication: 2018 Apr 04.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier-Masson SAS Country of Publication: France NLM ID: 101681234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2452-3186 (Electronic) Linking ISSN: 24523186 NLM ISO Abbreviation: Curr Res Transl Med

مواضيع طبية MeSH: Immunotherapy, Adoptive*/methods , Immunotherapy, Adoptive*/trends , Therapies, Investigational*/methods , Therapies, Investigational*/trends, Neoplasms/*therapy , Receptors, Chimeric Antigen/*therapeutic use , T-Lymphocytes/*physiology, Clinical Trials as Topic/methods ; Drug Approval ; Drug Industry ; Humans ; Neoplasms/immunology ; Receptors, Chimeric Antigen/genetics ; Receptors, Chimeric Antigen/metabolism ; Research Design ; T-Lymphocytes/transplantation ; United States ; United States Food and Drug Administration

المؤلفون: Lonez C; Celyad SA, Mont-Saint-Guibert, Belgium., Verma B; Celyad SA, Boston, MA, USA., Hendlisz A; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Aftimos P; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Awada A; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium., Van Den Neste E; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Catala G; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Machiels JH; Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium., Piette F; International Drug Development Institute, Louvain-la-Neuve, Belgium., Brayer JB; H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Sallman DA; H. Lee Moffitt Cancer Center, Tampa, Florida, USA., Kerre T; Ghent University Hospital, Ghent, Belgium., Odunsi K; Roswell Park Cancer Institute, Buffalo, New York, USA., Davila ML; H. Lee Moffitt Cancer Center, Tampa, Florida, USA.; Morsani College of Medicine, University of South Florida, Tampa, Florida, USA., Gilham DE; Celyad SA, Mont-Saint-Guibert, Belgium., Lehmann FF; Celyad SA, Mont-Saint-Guibert, Belgium.

المصدر: BMJ open [BMJ Open] 2017 Nov 12; Vol. 7 (11), pp. e017075. Date of Electronic Publication: 2017 Nov 12.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Research Design*, NK Cell Lectin-Like Receptor Subfamily K/*administration & dosage , Neoplasm Metastasis/*therapy , Neoplasms/*therapy, Belgium ; Female ; Humans ; Immunotherapy/adverse effects ; Male ; NK Cell Lectin-Like Receptor Subfamily K/metabolism ; Neoplasms/classification ; United States

المؤلفون: Cohen EEW; Moores Cancer Center, University of California San Diego, La Jolla, USA;. Electronic address: ecohen@ucsd.edu., Licitra LF; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan;; Department of Medical Oncology, University of Milan, Milan, Italy., Burtness B; Department of Medical Oncology, Yale University School of Medicine, New Haven, USA., Fayette J; Department of Medicine, Léon Bérard Center, Lyon;; Department of Medicine, Hospices Civils de Lyon, University of Lyon, Lyon, France., Gauler T; Department of Medicine, West German Cancer Center, University Hospital Essen of the University Duisburg-Essen, Essen, Germany., Clement PM; Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium., Grau JJ; Department of Medical Oncology, Hospital Clínic de Barcelona, University of Barcelona, Barcelona., Del Campo JM; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain., Mailliez A; Oncology Department Mastology, Centre Oscar Lambret, Lille, France., Haddad RI; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston;; Department of Medicine, Brigham and Women's Hospital, Boston, USA., Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium., Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Guigay J; Department of Medical Oncology, Centre Antoine Lacassagne, FHU OncoAge, Nice., Geoffrois L; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France., Merlano MC; Department of Medical Oncology, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy., Dupuis N; Biodesix Inc., Boulder, USA., Krämer N; Staburo GmbH, Munich, Germany on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Cong XJ; Biometrics and Data Management, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA., Gibson N; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Solca F; Pharmacology and Translational Research, Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria., Ehrnrooth E; TA Oncology, Boehringer Ingelheim, Danmark A/S, Denmark., Machiels JH; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques Universitaires Saint-Luc, Brussels;; Institut de Recherche Clinique et Expérimentale (Pole MIRO), Université Catholique de Louvain, Brussels, Belgium.

المصدر: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2017 Oct 01; Vol. 28 (10), pp. 2526-2532.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Carcinoma, Squamous Cell/*drug therapy , Carcinoma, Squamous Cell/*metabolism , Head and Neck Neoplasms/*drug therapy , Head and Neck Neoplasms/*metabolism , Methotrexate/*administration & dosage , Neoplasm Recurrence, Local/*drug therapy , Neoplasm Recurrence, Local/*metabolism , Quinazolines/*administration & dosage, Administration, Intravenous ; Administration, Oral ; Afatinib ; Antimetabolites, Antineoplastic/administration & dosage ; Biomarkers, Tumor/blood ; Biopsy ; Carcinoma, Squamous Cell/blood ; Carcinoma, Squamous Cell/pathology ; Disease-Free Survival ; Head and Neck Neoplasms/blood ; Head and Neck Neoplasms/pathology ; Humans ; Neoplasm Metastasis ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/pathology ; Predictive Value of Tests ; Squamous Cell Carcinoma of Head and Neck

المؤلفون: Machiels JH; Institut Roi Albert II, Service d'Oncologie Médicale, Cliniques universitaires Saint-Luc and Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain, 1200 Brussels, Belgium. Electronic address: jean-pascal.machiels@uclouvain.be., Coulie PG; de Duve Institute, Université catholique de Louvain, Brussels, Belgium.

المصدر: The Lancet. Oncology [Lancet Oncol] 2016 Jul; Vol. 17 (7), pp. 856-857. Date of Electronic Publication: 2016 May 27.

نوع المنشور: Journal Article; Comment

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Head and Neck Neoplasms*, Carcinoma, Squamous Cell/*immunology, Antibodies ; Antibodies, Monoclonal ; Humans